WEDNESDAY, Oct. 18, 2023 (HealthDay News) -- Many breast cancer survivors take a hormonal drug after cancer treatment to stave off a recurrence, but new research suggests these drugs may
Breast cancer cells in hormone-positive breast cancers are fueled by the female sex hormone estrogen. Aromatase inhibitor medications lower estrogen levels by stopping an enzyme in fat tissue called aromatase from changing other hormones into estrogen.
People are also reading… However, he added, “Treatment with aromatase inhibitors is still the treatment choice for this patient group and lowers the rate of breast cancer recurrence and in this patient group.” “The underlying mechanisms are multifactorial, and further clinical studies to understand how obesity is linked to breast cancer progression are needed,” Harborg said.
Listen now and subscribe: Apple Podcasts | Google Podcasts | Spotify | Stitcher | RSS Feed | Omny StudioWhile more studies are needed to see how weight affects the risk of breast cancer recurrence in women taking aromatase inhibitors, it is known that being overweight or obese increases the risk of complications after surgery to treat breast cancer, said Dr.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Eli Lilly's Obesity Drug Helped People Lose 25% of Their Weight in Latest TrialPeople who already lost weight at first went on to shed substantially more pounds than those on a placebo, Eli Lilly's newest clinical trial found.
Read more »
New 'Twincretin' Pemvidutide: Another Option for ObesityUnlike tirzepatide, which combines weight loss and glucose-lowering properties, this 'twincretin' reduces liver fat along with weight, blood pressure, and lipid levels.
Read more »
Is Childhood Obesity a National Public Health Emergency?While medical experts have viewed childhood obesity as an epidemic and a crisis for years, some are now saying it’s time to focus even more attention on the situation, and to do so earlier rather than later.
Read more »
Unlocking the Secrets of Fat Tissue: The Inflammatory Response in ObesityScience, Space and Technology News 2023
Read more »
Johnson & Johnson beats earnings estimates, downplays obesity drugs’ impact on its med-tech businessCompany raises full-year profit and sales guidance and pursues multipronged strategy to address talc-powder litigation
Read more »
Study reveals surprising insights into dog sterilization, obesityAs researchers continue to delve into the effects—both negative and positive—of spaying and neutering dogs, data included in a recent scientific publication in the Journal of the American Veterinary Medical Association indicate that obesity rates in sterilized dogs vary by breed size.
Read more »